Fingolimod Capsule
Product Images NDC 70377-019

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 70377-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Label

Fingolimod Capsules 0.5 mg oral capsule carton labeled for Biocon Pharma Inc. The label displays the NDC 70377-019-21, dosing information, and medication guide instructions. The packaging indicates each capsule contains 0.56 mg fingolimod hydrochloride equivalent to 0.5 mg fingolimod. The carton holds 28 capsules and includes safety instructions and manufacturer details.*

FDA Label Image

Bottle Label

Label for Fingolimod Capsules 0.5 mg, oral dosage form by Biocon Pharma Inc. The label shows the NDC 70377-019-11, package quantity of 30 capsules, usage storage instructions, and manufacturer information. It includes a barcode and designated space for batch coding and serialization printing.*

FDA Label Image

Figure 1

Chemical structure diagram of fingolimod hydrochloride, showing the molecular arrangement including a phenyl ring, hydroxyl groups, amine group with hydrochloride, and an aliphatic chain.*

FDA Label Image

Figure 2

A line graph showing the percentage of patients with three-month confirmed progression over time (in days) for Fingolimod 0.5 mg versus placebo. The x-axis represents time up to 720 days, and the y-axis represents the percentage of patients progressing. The graph compares treatment groups with Fingolimod and placebo, with final percentages of approximately 18% for Fingolimod and 24% for placebo at the study's end.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.